238 related articles for article (PubMed ID: 33526021)
41. An ELISA based on a truncated soluble ORF2 protein for the detection of PCV2 antibodies in domestic pigs.
Yin SH; Yang SL; Tian H; Wu JY; Shang YJ; Cai XP; Liu XT
Virol Sin; 2010 Jun; 25(3):191-8. PubMed ID: 20960293
[TBL] [Abstract][Full Text] [Related]
42. Development of an immunochromatographic strip for the detection of antibodies against Porcine circovirus-2.
Jin Q; Yang J; Lu Q; Guo J; Deng R; Wang Y; Wang S; Wang S; Chen W; Zhi Y; Wang L; Yang S; Zhang G
J Vet Diagn Invest; 2012 Nov; 24(6):1151-7. PubMed ID: 23051825
[TBL] [Abstract][Full Text] [Related]
43. Changes in peripheral blood leukocyte subpopulations in piglets co-infected experimentally with porcine reproductive and respiratory syndrome virus and porcine circovirus type 2.
Shi K; Li H; Guo X; Ge X; Jia H; Zheng S; Yang H
Vet Microbiol; 2008 Jun; 129(3-4):367-77. PubMed ID: 18164875
[TBL] [Abstract][Full Text] [Related]
44. Development of a Gold Nanoparticle-Based Immunochromatographic Strip for Rapid Detection of Porcine Circovirus Type 2.
Jiang M; Wang A; Sun Y; Li Y; Chen Y; Zhou J; Liu H; Ding P; Qi Y; Li N; Zhang G
Microbiol Spectr; 2023 Aug; 11(4):e0195322. PubMed ID: 37466437
[TBL] [Abstract][Full Text] [Related]
45. Protective efficacy of a virus-vectored multi-component vaccine against porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 and swine influenza virus.
Tian D; Sooryanarain H; Matzinger SR; Gauger PC; Karuppannan AK; Elankumaran S; Opriessnig T; Meng XJ
J Gen Virol; 2017 Dec; 98(12):3026-3036. PubMed ID: 29091579
[TBL] [Abstract][Full Text] [Related]
46. Retrospective serological survey of antibodies to porcine circovirus type 1 and type 2.
Magar R; Müller P; Larochelle R
Can J Vet Res; 2000 Jul; 64(3):184-6. PubMed ID: 10935885
[TBL] [Abstract][Full Text] [Related]
47. Enhancement of the immunogenicity of a porcine circovirus type 2 DNA vaccine by a recombinant plasmid coexpressing capsid protein and porcine interleukin-6 in mice.
Guo XQ; Wang LQ; Qiao H; Yang XW; Yang MF; Chen HY
Microbiol Immunol; 2015 Mar; 59(3):174-80. PubMed ID: 25664504
[TBL] [Abstract][Full Text] [Related]
48. Combined Antibody Tagged HRP Gold Nanoparticle Probe for Effective PCV2 Screening in Pig Farms.
Zhang S; Wang L; Wang L; Yu N; Dong Y; Hu J
Int J Nanomedicine; 2022; 17():3361-3369. PubMed ID: 35937078
[TBL] [Abstract][Full Text] [Related]
49. Effect of Maternal Antibody Transfer on Antibody Dynamics and Control of Porcine Circovirus Type 2 Infection in Offspring.
Dvorak CMT; Payne BJ; Seate JL; Murtaugh MP
Viral Immunol; 2018; 31(1):40-46. PubMed ID: 28817375
[TBL] [Abstract][Full Text] [Related]
50. Experimental reproduction of postweaning multisystemic wasting syndrome in cesarean-derived, colostrum-deprived piglets inoculated with porcine circovirus type 2 (PCV2): investigation of quantitative PCV2 distribution and antibody responses.
Okuda Y; Ono M; Yazawa S; Shibata I
J Vet Diagn Invest; 2003 Mar; 15(2):107-14. PubMed ID: 12661720
[TBL] [Abstract][Full Text] [Related]
51. Preclinical detection of porcine circovirus type 2 infection using an ultrasensitive nanoparticle DNA probe-based PCR assay.
Huang Y; Zhang X; Du Q; Wang F; Zhao X; Zhang W; Tong D
PLoS One; 2014; 9(5):e97869. PubMed ID: 24842840
[TBL] [Abstract][Full Text] [Related]
52. The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts.
Bucarey SA; Noriega J; Reyes P; Tapia C; Sáenz L; Zuñiga A; Tobar JA
Vaccine; 2009 Sep; 27(42):5781-90. PubMed ID: 19664739
[TBL] [Abstract][Full Text] [Related]
53. Markedly different immune responses and virus kinetics in littermates infected with porcine circovirus type 2 or porcine parvovirus type 1.
Opriessnig T; Gerber PF; Matzinger SR; Meng XJ; Halbur PG
Vet Immunol Immunopathol; 2017 Sep; 191():51-59. PubMed ID: 28895867
[TBL] [Abstract][Full Text] [Related]
54. Nanobody‑horseradish peroxidase and -EGFP fusions as reagents to detect porcine parvovirus in the immunoassays.
Lu Q; Li X; Zhao J; Zhu J; Luo Y; Duan H; Ji P; Wang K; Liu B; Wang X; Fan W; Sun Y; Zhou EM; Zhao Q
J Nanobiotechnology; 2020 Jan; 18(1):7. PubMed ID: 31910833
[TBL] [Abstract][Full Text] [Related]
55. Short communication: a modified Vaccinia virus Ankara-based Porcine circovirus 2 vaccine elicits strong antibody response upon prime-boost homologous immunization in a preclinical model.
de Oliveira Daian E Silva DS; Barbosa-Stancioli EF; Coelho-Dos-Reis JGA; Da Fonseca FG
Braz J Microbiol; 2020 Sep; 51(3):1439-1445. PubMed ID: 32144692
[TBL] [Abstract][Full Text] [Related]
56. PCV cap proteins fused with calreticulin expressed into polymers in Escherichia coli with high immunogenicity in mice.
Liu C; Liu Y; Feng H; Zhao B; Chen Y; Huang H; Wang P; Deng R; Zhang G
BMC Vet Res; 2020 Aug; 16(1):313. PubMed ID: 32854700
[TBL] [Abstract][Full Text] [Related]
57. The levels of PCV2 specific antibodies and viremia in pigs.
Carasova P; Celer V; Takacova K; Trundova M; Molinkova D; Lobova D; Smola J
Res Vet Sci; 2007 Oct; 83(2):274-8. PubMed ID: 17223145
[TBL] [Abstract][Full Text] [Related]
58. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
[TBL] [Abstract][Full Text] [Related]
59. A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs.
Matzinger SR; Opriessnig T; Xiao CT; Catanzaro N; Beach NM; Slade DE; Nitzel GP; Meng XJ
Virology; 2016 Nov; 498():82-93. PubMed ID: 27564544
[TBL] [Abstract][Full Text] [Related]
60. Assessment of neutralizing and non-neutralizing antibody responses against Porcine circovirus 2 in vaccinated and non-vaccinated farmed pigs.
Solis Worsfold C; Dardari R; Law S; Eschbaumer M; Nourozieh N; Marshall F; Czub M
J Gen Virol; 2015 Sep; 96(9):2743-2748. PubMed ID: 26033118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
